Health & Medicine
Cutting-edge developments in biomedical research, public health, and clinical practice at Harvard’s medical institutions.
Nicole Maestas
The Harvard health economist not afraid to get in the weeds
by Max J. Krupnick
The Pandemic’s “Perfect and Terrible Storm”
Seasonality and SARS-CoV-2
by Jonathan Shaw
Caroline Buckee: Can Mobile-phone Data Help Control the Spread of the Coronavirus?
Anonymized location data can help guide strategies for protecting public health in a pandemic.
The Upside
President Bacow remains positive despite the pandemic.
by John S. Rosenberg
Crimson Red Ink
Harvard reports lower revenues and a loss for the year, as the pandemic’s sweeping effects begin to take hold.
by John S. Rosenberg
Spring Remains Remote
Harvard professional schools continue (mostly) online learning during the next semester—and other indicators for 2021.
by John S. Rosenberg
The $16-Trillion Virus
Economic damage makes a compelling argument for robust federal policies to reduce the spread of SARS-CoV-2.
by Jonathan Shaw
Fraught Fall
A semester conducted in the shadow of the coronavirus
by John S. Rosenberg
Timely Recovery
The endowment increases to $41.9 billion, and Harvard Management Company reports a 7.3 percent return on investments.
by John S. Rosenberg
Harvard Endowment Valued at $41.9 Billion, Up 2.4 Percent
Harvard Management Company reports a 7.3 percent return on endowment investments.
by John S. Rosenberg
“An Academic Year in an Age of Upheaval”
President Bacow’s somber opening message for a challenging academic year—updated to include his Morning Prayers remarks
by John S. Rosenberg